Infections in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: findings from an international collaboration of registers (the “JAK-POT” study)
04/09/2024
R. Aymon1, D. Mongin1, B. Gilbert1, R. Guemara1, D. Choquette2, C. Codreanu3, I. Flouri4, D. Huschek5, K. Hyrich6, F. Iannone7, L. Kearsley-Fleet8, T. K. Kvien9, B. F. Leeb10, D. Nordström11, K. Pavelka12, M. Pombo-Suarez13, S. Aarrestad Provan9, A. M. Rodrigues14,15, Z. Rotar16, P. Sidiropoulos17, A. Strangfeld18,19, N. Trokovic11, J. Zavada12, D. S. Courvoisier1, A. Finckh1, K. Lauper1
EULAR 2024
DOI: 10.1136/annrheumdis-2024-eular.1769
https://ard.bmj.com/content/83/Suppl_1/84